1,642
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Ototoxicity monitoring through the eyes of the treating physician: Perspectives from pulmonology and medical oncology

ORCID Icon, , , , &
Pages S42-S47 | Received 14 Feb 2017, Accepted 14 Sep 2017, Published online: 05 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dawn Konrad-Martin, Gayla L. Poling, Angela C. Garinis, Candice E. Ortiz, Jennifer Hopper, Keri O’Connell Bennett & Marilyn F. Dille. (2018) Applying U.S. national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions. International Journal of Audiology 57:sup4, pages S3-S18.
Read now

Articles from other publishers (11)

David S. Lee, Emma Y. Travis, Susan K. Wong, Cathryn Collopy, Katrina S. McClannahan, Amanda J. Ortmann, Jason T. Rich, Patrik Pipkorn, Sidharth V. Puram, Ryan S. Jackson, Randal C. Paniello, Douglas R. Adkins, Peter Oppelt, Wade L. Thorstad, Cameron C. Wick, Jose P. Zevallos & Angela L. Mazul. (2023) Audiologic Follow‐up in Patients With Head and Neck Cancer Treated With Cisplatin and Radiation. The Laryngoscope 133:11, pages 3161-3168.
Crossref
Stephanie E. Pearson, Charlotte Caimino, Maryam Shabbir & David M. Baguley. (2021) The impact of chemotherapy-induced inner ear damage on quality of life in cancer survivors: a qualitative study. Journal of Cancer Survivorship 16:5, pages 976-987.
Crossref
Colleen G. Le Prell, Carmen C. Brewer & Kathleen C. M. Campbell. (2022) The audiogram: Detection of pure-tone stimuli in ototoxicity monitoring and assessments of investigational medicines for the inner ear. The Journal of the Acoustical Society of America 152:1, pages 470-490.
Crossref
Colleen G. Le Prell. (2022) Prevention of Noise-Induced Hearing Loss Using Investigational Medicines for the Inner Ear: Previous Trial Outcomes Should Inform Future Trial Design. Antioxidants & Redox Signaling 36:16-18, pages 1171-1202.
Crossref
Katerina Ehlert, Barbara Heinze & De Wet Swanepoel. (2022) Ototoxicity monitoring in South African cancer facilities: A national survey. South African Journal of Communication Disorders 69:1.
Crossref
N. M. Santucci, B. Garber, R. Ivory, M. A. Kuhn, M. Stephen & D. Aizenberg. (2021) Insight into the current practice of ototoxicity monitoring during cisplatin therapy. Journal of Otolaryngology - Head & Neck Surgery 50:1.
Crossref
Dawn Konrad-Martin, Keri O'Connell Bennett, Angela Garinis & Garnett P. McMillan. (2021) A Randomized Controlled Trial Using Automated Technology for Improving Ototoxicity Monitoring in VA Oncology Patients. American Journal of Audiology 30:3S, pages 870-886.
Crossref
Angela C. Garinis, Gayla L. Poling, Ronald C. Rubenstein, Dawn Konrad-Martin, Timothy E. Hullar, David M. Baguley, Holly L. Burrows, Jennifer A. Chisholm, Amy Custer, Laura Dreisbach Hawe, Lisa L. Hunter, Theodore K. Marras, Candice E. Ortiz, Lucretia Petersen, Peter S. Steyger, Kevin Winthrop, Erika M. Zettner, Khaya Clark, Michelle Hungerford, Jay J. Vachhani & Carmen C. Brewer. (2021) Clinical Considerations for Routine Auditory and Vestibular Monitoring in Patients With Cystic Fibrosis. American Journal of Audiology 30:3S, pages 800-809.
Crossref
Chelsea M. Blankenship, Lisa L. Hunter, M. Patrick Feeney, Madison Cox, Lindsey Bittinger, Angela C. Garinis, Li Lin, Gary McPhail & John P. Clancy. (2021) Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort. American Journal of Audiology 30:3S, pages 834-853.
Crossref
Dawn Konrad-Martin, Neela Swanson & Angela Garinis. (2019) A Guide to Coding and Billing for the Audiological Management of Patients Receiving Ototoxic Medical Treatments. Perspectives of the ASHA Special Interest Groups 4:5, pages 936-946.
Crossref
Kathleen C. M. Campbell & Colleen G. Le Prell. (2018) Drug-Induced Ototoxicity: Diagnosis and Monitoring. Drug Safety 41:5, pages 451-464.
Crossref